GynecologyNews.net

Gynecology Xagena

Search results for "Herceptin"

Two Phase III trials of Herceptin ( Trastuzumab), a monoclonal antibody, were stopped early after a preliminary joint interim analysis demonstrated an improvement in disease-free survival and in overa ...


NICE has recommended Herceptin ( Trastuzumab ) for women with early stage HER2-positive breast cancer, except where there are concerns about the woman’s cardiac function. The recommendations are as ...


Researchers at The University of Texas MD Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs ...


Combining two chemotherapy drugs with Trastuzumab ( Herceptin ) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.Researchers at May ...


Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not exp ...


One year of adjuvant treatment with the targeted drug Trastuzumab ( Herceptin ) is as good as two years of treatment, for women with HER2-positive early breast cancer who have already received initial ...


A randomized, non-inferiority trial conducted by the French National Cancer Institute ( INCa ) has compared a shorter Trastuzumab ( Herceptin ) exposure of 6 months versus the standard 12 months treat ...


Data from a pooled analysis presented today at the 50th Annual Meeting of the American Society of Clinical Oncology ( ASCO ) have provided further evidence that Eribulin ( Halaven ) improves overall s ...